Journal article
Effect of Early Treatment with Ivermectin among Patients with Covid-19
Abstract
BACKGROUND: The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear.
METHODS: We conducted a double-blind, randomized, placebo-controlled, adaptive platform trial involving symptomatic SARS-CoV-2-positive adults recruited …
Authors
Reis G; Silva EASM; Silva DCM; Thabane L; Milagres AC; Ferreira TS; Dos Santos CVQ; Campos VHS; Nogueira AMR; de Almeida APFG
Journal
The New England Journal of Medicine, Vol. 386, No. 18, pp. 1721–1731
Publisher
Massachusetts Medical Society
Publication Date
May 5, 2022
DOI
10.1056/nejmoa2115869
ISSN
0028-4793